Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 50 Rectal Neoplasms 49 Colorectal Neoplasms 36 Pancreatic Neoplasms 10 Unspecified Adult Solid Tumor, Protocol Specific 9 Neoplasm Metastasis 8 Stomach Neoplasms 7 Ovarian Neoplasms 6 Carcinoma, Hepatocellular 6 Lymphoma, Large B-Cell, Diffuse 5 Gallbladder Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Bile Duct Neoplasms 5 Burkitt Lymphoma 4 Appendiceal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroblastoma 3 Neoplasms 3 Fallopian Tube Neoplasms 3 Uterine Cervical Neoplasms 2 Testicular Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Osteosarcoma 2 Optic Nerve Glioma 2 Neurotoxicity Syndromes 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Nasopharyngeal Neoplasms 2 Melanoma 2 Lymphoma, T-Cell, Peripheral 2

Interventions

veliparib 1 belinostat 1 Paclitaxel 1 Oxaliplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Liver Diseases × Oxaliplatin × Clear all

NCT00006062 2008-03-04

Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡